Torsdag 26 December | 20:01:32 Europe / Stockholm

Prenumeration

2024-05-13 08:23:00

Redeye updates its outlook and fair value range on Lifecare following the company’s Q1 report and announced capital raise. We believe that the company stands before an exciting H2 containing a rich news flow, we also give our initial take on the veterinary product expected to launch in the near term.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/